MBS511 - How to deliver democratized access to cardiac care - Dr. Waqaas Al-Siddiq CEO Biotricity (Built in California #29)

Send us a text

Biotricity creates leading-edge professional and personal remote medical monitoring technology engineered to improve people's lives. Biotricity listed on the Nasdaq only 5 years into their journey. 

Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, has surpassed $10 million in annual revenue run rate. 

Biotricity boasts multiple ground-breaking products including Bioflux®, Biotres, and Bioheart which won TIME's Best Inventions of 2022. 

Bioflux: a high-precision, single-unit mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of your ECG information to your doctor 

Biotres: an easy to wear, rechargeable device with wireless capability, utilizing the advanced technology of the Bioflux® for more active days 

Bioheart: a consumer-targeted continuous heart rhythm monitor that uses the most advanced heart technology to deliver unlimited heart data insights with three views of your heart

Get interviewed on the Matt Brown Show: www.mattbrownshow.com

Support the show